Special notice, 8(a) sole source
Regent of the University of Minnesota
NIMH25007624
National Institutes of Health, National Institutes of Health. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
August 9, 2025 at 12:00 PM EDT
Closed 404 days ago. Posted July 25, 2025. Scheduled to archive August 24, 2025.
Description
As published on SAM.gov.
Autoimmune diseases as single entities may be rare, but collectively afflict tens of millions of Americans and disproportionately impact women. Moreover, autoimmune diseases tend to co-occur in a person and are linked to many age-related conditions. In general, autoimmune diseases are underdiagnosed and involve autoantibodies that appear decades before the disease onset. Some autoimmune diseases occur more frequently in Hispanics, like systemic lupus erythematosus.
Using a multiplex assay of autoantibodies to detect subclinical and preclinical autoimmune diseases, we propose assessing their seroprevalence in the Hispanic population and investigating the autoantibody associations with various antibodies to infection and age-related conditions.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 25, 2025
Special notice
Due August 9, 2025 at 12:00 PM EDT. SAM.gov, notice e726c279425741e98089d5db3a3a7dd2
Points of contact
- Joseph Kennedyjoseph.kennedy@nih.gov